ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Rabbit Anti-Thymocyte Globulin (rATG) Induction in Heart Transplant Recipients at High Risk for Rejection

    B. Kitto1, B. Baetz1, S. Krim2, H. Patel2, S. Mandras2, S. Desai2, C. Eiswirth2, H. Ventura2, S. Thai1

  • Race-Sex Effects on Immune Response Potential during Tacrolimus Minimization Therapy in Stable Renal Allograft Recipients

    K. Tornatore1, K. Attwood2, R. Venuto3, H. Minderman4

  • Racial and Ethnic Differences in Physician Trust and Hypertension Treatment Adherence among Living Kidney Donors in the United States

    J. S. Wilson Jr1, L. Cooper2, M. Johnson2, M. Waldram2, Y. Yu2, J. Perkins2, D. Crews2, N. Lacy3, M. Henderson2, A. Massie2, K. Lentine4, D. Segev2, T. Purnell2

  • Racial and Ethnic Disparities in Access to Living Donor Kidney Transplantation in the US: Have We Made Any Progress among Pediatric Candidates over the Last Twenty Years?

    T. Purnell1, S. Bae1, X. Luo1, A. Chen1, D. Crews1, L. Cooper1, O. N. Bignall II2, K. Covarrubias1, D. Segev1

  • Racial and Income-Based Disparities in Access to Kidney Transplantation in the Context of a Nationally-Financed Health System in Brazil

    A. Saha1, G. Ferreira2, Y. Yu1, M. Waldram1, V. Colares2, J. Bastos2, M. Henderson1, D. Segev1, A. Massie1

  • Racial Differences in Acute Kidney Injury Occurrence among Deceased Kidney Donors

    M. Doshi1, I. Hall2, S. Mohan3, C. Liu4, H. Philbrook4, P. Reese5, S. Mansour6, F. Weng7, E. Akalin8, J. Bromberg9, M. Harhay10, T. Muthukumar11, B. Schroeppel12, P. Singh13, C. Parikh4

  • Racial Differences in Cancer Mortality for Kidney Transplant Recipients

    K. Cordrey, J. Motter, A. Kernodle, K. Jackson, M. Camp, T. Purnell, D. Segev, J. Garonzik Wang

  • Racial Disparities in Documentation of Non-Adherence and Its Relation to Rejection in Pediatric Kidney Transplant Recipients

    T. Melanson, J. Hogan, K. Maroney, R. Patzer, R. George

  • Racial Disparity in Pre-Kidney Transplant Work-Up

    J. Buggs1, H. Mohamed2, C. Myer3, S. Lloyd4, E. Rogers1, H. Pearson1, J. Clement1, D. Zunick1, A. Kumar2, V. Bowers1

  • Racial Variation in ESRD Diagnosis Patterns among Prior Living Kidney Donors on the OPTN Kidney Waiting List

    J. Wainright1, A. Robinson1, A. Wilk1, D. Klassen2, W. Cherikh1, C. Custer1, R. Brown3, D. Stewart1

  • Racial/Ethnic and Socio-Economic Disparities: Single versus Multi-Organ Transplant Recipients

    C. A. Custer1, K. Ladin2, J. Entwistle3, E. J. Gordon4

  • Randomized Controlled Trial Of Spironolactone Effect In Kidney Transplant Recipients Of Living Donors

    N. A. Bobadilla1, L. E. Morales-Buenrostro1, J. A. Ortega-Trejo1, R. Perez-Villalva1, L. Marino1, Y. González-Bobadilla1, H. Juarez1, F. Zamora-Mejía1, N. Gonzalez1, R. Espinoza2, J. Barrera-Chimal3

  • Rapid Detection of Kidney Transplant Injury by Quantifying Donor-Derived Cell-Free Deoxyribonucleic Acid via Massively Multiplex Polymerase Chain Reaction

    T. K. Sigdel1, F. Acosta2, S. Navarro2, B. Zimmermann2, Z. P. Demko2, S. Moshkevich2, P. R. Billings2, M. M. Sarwal1

  • Rapid Growth of HCV-Infected Donors for HCV-Uninfected Kidney and Liver Transplant Recipients in the United States

    M. Bowring, A. Shaffer, A. Massie, N. Desai, M. Sulkowski, A. Cameron, J. Garonzik-Wang, D. Segev

  • Rcor1 and Regulation of Foxp3+ T-Regulatory Cells In Vitro and In Vivo

    Y. Xiong, L. Wang, R. Han, W. W. Hancock

  • Ready for Prime Time: Intentional Allocation of Hepatitis C Positive Livers into Hepatitis C Negative Recipients

    P. N. Martins1, B. Movahedi1, D. Devuni2, P. Mahboub1, A. Bozorgzadeh1

  • Real World Data Support International Consenus Guidelines on Management of CMV after Kidney Transplantation

    A. Asberg, G. B. Kro, A. V. Reisæter, A. Hartmann, K. Midtvedt

  • Real World Impact of HCV Viremic Solid Organs on Waitlist Times

    N. Kapila1, A. Ur Rahman1, K. Gupta2, K. Al Khalloufi3, E. Navas3, D. Reino3, S. Ebaid3, N. Agarwal3, J. Shaw3, C. Murgas3, S. Rhazouani3, A. Zeeshan3, A. Tzakis3, C. Sheffield3, J. Vanatta3, X. Zervos3

  • Real-Life Food Safety Behavior and Incidence of Food-Borne Infections in Solid-Organ Transplant Recipients

    M. Lindup, D. Golshayan, M. Pascual, O. Manuel, M. Mombelli

  • Recipient and Donor Factors at the Time of Transplant as Predictors of Graft Outcomes

    K. Soliman1, V. Rohan2, S. Zemin1, A. Price1, A. P. Salas1, D. Lazarus1, M. Casey3, D. J. Taber2, V. Rao3

  • Recipient Antibiotics Pretreatment Protects Liver Transplants from Ischemia-Reperfusion Injury via Prostaglandin E2: From Bench-to Bedside

    K. Nakamura, S. Kageyama, T. Ito, H. Hirao, K. Kadono, K. J. Dery, J. Aziz, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Recipient Monocytes Activated by Endobronchial Toll-Like Receptor 2 Agonist Prevent Tolerance Induction after Lung Transplantation

    S. Tanaka1, J. M. Gauthier1, Y. Terada1, T. Takahashi1, W. Li1, R. Higashikubo1, A. Y. Tong1, V. Puri1, A. S. Krupnick2, A. E. Gelman1, D. Kreisel1

  • Recipient Myeloid Notch1 Disruption Shifts Neutrophil towards Anti-Inflammatory Phenotype and Protects Liver Grafts from Ischemia-Reperfusion Injury

    S. Kageyama1, H. Hirao1, K. Kadono1, K. Nakamura1, K. J. Dery1, T. Ito2, D. Oncel1, J. Aziz1, B. Ke1, F. M. Kaldas2, R. W. Busuttil2, J. W. Kupiec‐Weglinski1

  • Recipient Outcomes Following Transplantation Of Allografts From Older Live Kidney Donors With Hypertension

    F. Al Ammary1, S. Yu2, A. D. Muzaale3, D. C. Brennan4, A. C. Wiseman5, D. L. Segev3, A. B. Massie3

  • Recipient Predictors of Post-Donation End Stage Renal Disease in Living Kidney Donors

    J. Wainright1, A. Robinson1, A. Wilk1, D. Klassen2, W. Cherikh1, L. Cartwright1, D. Stewart1

  • Recipient Sex Interacts with Primary Diagnosis to Affect Liver Transplant Graft Survival

    D. Yoeli1, R. Choudhury1, H. Moore1, M. Simpson2, A. Sauaia1, E. Pomfret1, T. Nydam1

  • Recipient TIM4 Expression is Essential for Hepatocellular Function in Liver Transplantation

    K. Kadono, S. Kageyama, H. Hirao, K. Nakamura, K. J. Dery, D. Oncel, T. Ito, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Recipients with Model for End-Stage Liver Disease Sodium Score Driven by Renal Dysfunction Have Increased Post-Transplant Mortality

    T. Bittermann, D. Goldberg

  • Recombinant Apoptosis Inhibitor of Macrophage Protein Ameliorates Transplant Ischemia-Reperfusion Injury

    J. Y. Lee1, X. Zhang2, D. Lian3, A. R. Haig4, T. Miyazaki5, L. Gunaratnam6

  • Recurrent Diabetic Nephropathy Despite Intensive Glycemic Control: An Observational Cohort Study

    M. Coemans, E. Van Loon, E. Lerut, D. Kuypers, B. Sprangers, P. Gillard, C. Mathieu, G. Verbeke, M. Naesens

  • Redefining Cirrhotic Cardiomyopathy; A Shifting Paradigm

    M. J. Izzy1, M. Angirekula2, M. Leise2, A. Allen2, K. Watt2

  • Redox State of HMGB1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation

    R. A. Sosa1, A. Q. Terry1, J. Nevarez-Mejia1, M. Rossetti1, B. V. Naini1, V. M. Groysberg1, F. M. Kaldas2, R. W. Busuttil2, D. W. Gjertson1, J. W. Kupiec-Weglinski2, E. F. Reed1

  • Reduced Intensity Induction Therapy in Patients Undergoing Repeat Kidney Transplants

    K. Linhares, M. Cristelli, C. Felipe, L. Viana, H. Proença, R. E. de Marco, J. Pestana, H. Tedesco

  • Reduction In Early Readmission In Kidney Recipients – Outcomes At One Year With Standardized Intensive Follow Up

    A. Crane, M. Eltemamy, R. Fatica, E. Poggio, C. Modlin, A. Wee, V. Krishnamurthi

  • Reduction in Waitlist Time Using HCV Positive Liver Grafts in HCV Negative Recipients

    E. M. Bugeaud, N. Bzowej, J. Hand, J. Scheuermann, H. Bohorquez, C. Brown, D. Bruce, I. Carmody, A. Cohen, S. Joshi, N. Latt, J. Seal, D. Sonnier, G. Therapondos, G. Tyson, N. Girgrah, G. Loss

  • Reduction of Circulating DSA: Does It Affect Histology?

    M. Gupta1, E. Edusei1, S. Tsai2, M. Magruder2, J. Lee1, J. Lee1, C. Hartono1, T. Muthukumar1, M. Everly3, D. Dadhania1

  • Reduction of Pre-Existing Alloantibodies in Highly Sensitized Belatacept-Treated Kidney Recipients

    R. F. Parsons1, S. Bumb2, H. Decker1, A. Zahid1, C. Sullivan1, T. Pearson1, C. Larsen1, M. Levine3, M. Kamoun3, R. A. Bray1, H. M. Gebel1

  • Reevaluating Cut-Off Points for the Expansion of Deceased Donor Criteria for Kidney Transplantation in Japan

    Y. NAKAGAWA1, M. Masahiro2, M. Tasaki2, K. Saito3, K. Takahashi4

  • Reference Ranges Donor-Derived Cell-Free DNA in a Heart Transplant Population

    A. Kao1, S. Dholakia2, M. Deng3

  • Regeneration of Kidney with a Novel Biomimetic Vascular Scaffold

    S. Min1, H. Mo1, A. Han1, J. Ha1, J. Yoo2

  • Regional Differences in Transplantation for Expected Post-Transplant Survival Top 20% Candidates

    S. Husain, K. King, D. Tsapepas, G. Dube, D. Cohen, L. E. Ratner, S. Mohan

  • Regional Disparities In The Transplant Rates Across Unos Regions Pre- And Post-kidney Allocation System Policy Implementation

    A. C. Perez-Ortiz, E. Heher, N. Elias

  • Regulating T Cell Responses by Forced Transgenic Expression of Decay-Accelerating Factor

    D. Heja1, Z. He1, S. A. Lira1, F. Lin2, D. Homann1, P. S. Heeger1

  • Regulation of Host microRNA Expression by Natural Variants of Epstein Barr Virus (EBV) Latent Membrane Protein 1 (LMP1)

    O. Hatton1, A. Harris-Arnold2, A. Hui2, E. Maloney2, S. M. Krams2, O. M. Martinez2

  • Regulatory T Cells Combined with Costimulation Blockade Prevent Rejection of Vascularized Composite Allografts

    B. Oh1, G. Furtmüller1, M. Grzelak1, L. Vuong2, M. Iglesias1, M. Fryer3, D. Cooney1, R. Chen4, Y. Guo5, W. Lee1, G. Raimondi1, G. Brandacher1

  • REHANNA: Renal Transplants in Hepatitis C Negative Recipients with Nucleic Acid Positive Donors with Short Course Direct Acting Antiviral Prophylaxis

    C. Durand, B. Barnaba, D. Brown, N. Bair, F. Naqvi, M. Bowring, D. Segev, M. Sulkowski, N. Desai

  • Rejection Of Optic And Sciatic Transplants

    M. Yonar1, M. Uehara1, V. Kasinath1, F. Bei2, R. Abdi1

  • Rejection, Infectious, and Renal Outcomes with Perioperative Desensitization in Orthotopic Heart Transplant Recipients

    M. Plazak, B. Reed, S. Hammad, S. Gale, V. Ton, D. Kaczorowski, T. Trobiano, B. Ravichandran

  • Relationship between Comorbilities and Infectious Disease in Kidney Transplant Recipients Receiving Rituximab

    A. Molina-Andújar1, E. Hermida1, J. Rovira2, F. Cofan1, P. Ventura-Aguiar1, N. Esforzado1, V. Torregrosa1, D. Cucchiari1, E. de Souza1, I. Revuelta1, F. Oppenheimer1, F. Diekmann1, G. Piñeiro1

  • Relationship between HLA-DPB1 Gene Expression in Pre-Implantation Kidney Biopsies, Rs9277534 Polymorphism, and Late Graft Function

    K. L. Mine1, T. B. Mourão1, C. Felipe2, G. F. Rampim1, J. O. Medina-Pestana2, H. Tedesco-Silva2, M. Gerbase-DeLima1

  • Renal Allograft Survival after Dual Kidney Transplantation is at Least as Favorable as Outcome after Expanded Criteria Donor Kidney Transplantation

    A. Brar1, M. Sattar1, A. Gruessner1, R. M. Jindal2, R. Nee3, R. Gruessner1, M. Salifu1

  • Renal Cell Carcinoma in Dialysis Patients: Criteria for Transplant Wait List Inclusion

    D. B. Laskar1, J. Zeng1, S. Sharma2, M. T. Smith Jr3, A. D. Nicastri1, D. Levitan4, R. Maglantay1, D. John3, S. R. Gottesman1

  • Renal Failure after Liver Transplantation: Benefits from a Little Pinch of KALT

    R. Ruiz1, K. Holmes2, G. McKenna1, N. Onaca1, G. Testa1, H. Fernandez1, J. Bayer1, A. Wall1, E. Martinez1, E. Martinez1, A. Gupta1, R. Goldstein1, G. Klintmalm1

  • Renal Failure as a Complication of Vascularized Composite Allotransplantation

    R. N. Barth1, J. T. Shores2, G. Brandacher2, M. H. Levine3, A. Weissenbacher4, A. J. Nam1, N. Shockcor1, E. D. Rodriguez5, S. Schneeberger4, W. Lee2, S. T. Bartlett1, L. Levin3

  • Renal Function between Tenofovir and Entecavir in Post-Liver Transplanted Hepatitis B Patients

    S. Kim, J. Kim, S. Lee, J. Rhu, Y. Chung, S. Kim, J. Joh, S. Lee, G. Choi, J. Park, S. Lee, K. Lee

  • Renal Function, Albuminuria, and the Risk of Hemorrhage and Thrombosis after Kidney Transplantation

    N. N. Lam1, P. Ravani2, R. R. Quinn2, M. Tonelli2, F. Ye1, B. R. Hemmelgarn2, M. M. Sood3

  • Renal Outcomes from Expander-1: Pilot Study of HCV+ Donor Kidneys for HCV- Kidney Recipients

    S. Thaduri1, C. Durand1, N. Desai2, D. Segev2, N. Bair1, D. Brown1, F. F. Naqvi1

  • Renal Pathological Findings in Living Kidney Donor Candidates with Minimal Urinary Abnormalities

    H. Ahmed1, C. Drachenberg2, R. Ugarte1, N. Costa1, C. Cangro1, R. N. Barth3, M. Weir1, A. Harirain1

  • Renal Recovery and Prognostic Factors in Children Following Liver Transplantation

    R. Büscher, N. Gantenberg, A. Büscher, E. Lainka, P. Hoyer

  • Renal Safety Of Entecavir And Tenofovir With Hepatitis B Immunoglobulin In Liver Transplant Patients

    D. Kim1, J. Lee1, E. Kim1, S. Kim1, K. Ihn1, D. Joo1, K. Huh1, B. Kim2, M. Kim1, S. Kim1, Y. Kim1, J. Lee1

  • Renal Transplantation and Sleep: What do Patients Distress for?

    L. Long, J. Liu, J. Xie, J. Yan

  • Renal Transplantation from a Living Donor with a Horseshoe Kidney

    J. CHOI, J. Jung, J. Kim, H. Kwon, S. Shin, Y. Kim, D. Han

  • Renal Transplantation in Patients Older Than 60 Years with High Comorbidity. Is There a Survival Benefit? A Multicenter Study in Argentina

    G. D. Fragale1, G. A. Laham2, L. Bisignano3, A. Antik3, P. M. Raffaele4, M. Fortunato4, H. Trimarchi5, V. Pomeranz5, R. Maldonado6, N. Matamala6, N. C. Imperiali7, M. C. Giordani7, M. F. Taylor8, J. M. Ciappa8, J. L. De La Fuente9, S. Naser10, G. Soler Pujol2

  • Renoportal Anastomosis in Liver Transplantation: Results from a Propensity Score-Based Outcome Analysis

    G. D'Amico, S. Armanyous, L. Lomaglio, T. Diago Uso, K. Hashimoto, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, H. Matsushima, C. Lindenmeyer, C. Miller, C. Quintini

  • Repeat Liver Transplantation after Failed First Transplant in Childhood: Development of a Retransplant Risk Index

    M. Gupta1, M. Barry2, M. Levine3, K. Olthoff3, A. Shaked3, P. Abt3

  • Repeat-Pancreas Transplant after Pancreas Graft Failure in Simultaneous Pancreas and Kidney Transplants is Associated with Better Kidney Graft Survival

    S. Parajuli, A. Arunachalam, K. Swanson, F. Aziz, N. Garg, R. Redfield, D. Kaufman, A. Djamali, J. Odorico, D. Mandelbrot

  • Replication of Diagnostic Biomarkers Using Orthogonal State-of-the-Art Technologies

    M. Cassidy, B. Dooley, A. Verma, H. Yang, T. Muthukumar, R. Ding, C. Li, C. Snopkowski, B. Botticelli, S. Albakry, E. Edusei, M. Lubetzky, D. Dadhania, J. Lee, O. Elemento, M. Suthanthiran

  • Report of 20 HLAMatchmaker Eplets Present on Denatured Class I HLA Molecules

    R. de Marco1, A. C. Lima2, N. F. Pereira2, M. Gerbase-DeLima1

  • Requirements Of A Successful Pediatric To Adult Transition Program For Kidney Transplant Recipients. A Single Center Experience.

    H. Youness, D. Zepeda-Orozco, L. Harshman, S. Kuppachi

  • Resistance of T Follicular Helper Cells to Depletion by Anti-Thymocyte Globulin

    M. Pérez-Sáez1, N. Murakami2, T. J. Borges2, P. T. Sage2, J. Pascual1, L. V. Riella2

  • Resolution of Hyperglycemia Following Islet Allograft Transplantation in Non-Immunosuppressed Mice

    J. Ge1, K. Lee1, C. Yang1, R. White2, I. Rosales2, P. Russell1, C. Rickert1, J. Markmann1, J. Madsen1, R. Colvin2, A. Alessandrini1

  • Resource Utilization in Hepatocellular Carcinoma Liver Transplantation before and after the Six Month Wait Time

    J. Sokolich1, W. McClellan2, J. Buggs1, E. Rogers1, K. Barber1, K. Cocuy1, A. Kumar2

  • Respiratory Viral Infections and Patient Outcomes in Solid Organ Transplant Recipients

    M. Gonzalez1, A. Vostal1, N. Darling2, C. Papastamelos2, M. Natarajan3, P. Kumar3, J. Timpone3

  • Responder B Cell Depletion Increased Allo-Reactive Regulatory T Cells Generated in Allo-Anergization

    N. Tanimine1, L. Contreras-Ruiz2, K. Deng1, N. Feeney1, C. Rickert1, K. Lee1, E. Guinan3, J. Markmann1

  • Response to Treatment in Kidney Recipients with Acute T Cell-Mediated Rejection: Major Impact of Inflammation in Sclerotic Cortical Parenchyma (i-IF/TA) and Donor-Specific Antibodies

    Y. Bouatou, D. Viglietti, D. Pievani, J. Duong Van Huyen, O. Aubert, D. Glotz, C. Legendre, A. Loupy, C. Lefaucheur

  • Restrictive Medicaid Policies Reduce Access to Liver Transplant for Alcohol-Associated Liver Disease

    B. P. Lee, V. Eric, P. Mark, J. Dodge, N. Terrault

  • Results from the LIVE-C Free Trial

    J. N. Fleming1, D. DuBay1, N. L. Jonassaint2, R. S. Satoskar3, K. D. Chavin4

  • Results of Litmus (nct 02541916): The Liver Immune Tolerance Bio Marker Utilization Study

    A. Chruscinski1, V. Rojas-Luengas1, S. Moshkelgosha1, J. Luo2, H. Yowanto2, Z. Galvin1, L. Lilly1, R. Smith1, E. Renner1, J. Zhang1, D. Grant1, O. Adeyi1, H. Atkins3, P. Juni4, N. Selzner1, S. Juvet1, G. Levy1

  • Retroperitoneoscopic Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease

    K. Hotta1, D. Iwami2, J. Furumido2, K. Morita3, T. Tanabe4, T. Mochizuki4, H. Higuchi2, N. Iwahara2, T. Abe2, K. Kanagawa4, N. Shinohara2

  • Retrospective Evaluation of Dapsone Prophylaxis Complications in Kidney Transplant Recipients

    S. Hamel1, V. Johnson2, D. Johnson2, E. Blumberg3, R. Bloom4, J. Trofe-Clark2

  • Retrospective Evaluation of Optimal Cmv Prophylaxis Regimens in Lung Transplant Patients: Analysis of Patient Outcomes Pre and Post Protocol Dosing Alterations

    J. Hunt, A. Nasar, R. Walia, L. Cherrier

  • Retrospective Nested Case Control Study of the Impact of Immunosuppression on Post Transplant Malignancy among Adult Heart Transplant Patients

    S. Crow, R. J. Bubik, S. S. Kushwaha, K. C. Mara, R. A. Dierkhising, N. L. Pereira

  • Return to Work after Sick Leave in Kidney Transplant Recipients: A 365-Day Cohort of the Japan Academic Consortium of Kidney Transplantation (JACK) Study

    K. Miyake1, M. Okumi1, K. Unagami2, Y. Kakuta1, M. Furusawa1, K. Omoto3, T. Shimizu3, M. Endo4, H. Ishida2, K. Tanabe1

  • Reverse Signaling through CD137 Ligand Promotes Tissue Repair after Ischemia-Reperfusion Kidney Injury

    H. R. Cho1, S. Lee2, J. S. Lee3, S. J. Park1, B. Kwon2

  • Risk Factors for 1-5 Year De Novo Cancers after Kidney Transplant (KTx) with First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression by Efficacy and Morbidity (CISTEM) Study

    V. Dharnidharka1, D. Axelrod2, Z. Zhang3, M. Schnitzler3, K. Lentine3, B. Kasiske4

  • Risk Factors for 1-5 Year Major Infection Events (MIE) after Kidney Transplant (KTx) Including First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity (CISTEM) Study

    V. Dharnidharka1, D. Axelrod2, Z. Zhang3, M. Schnitzler3, K. Lentine3, B. Kasiske4

  • Risk Factors for Graft Loss Vary with Recipient MELD Score in Liver Transplantation

    J. A. Steggerda1, M. B. Bloom1, T. Todo2, T. V. Brennan2, N. N. Nissen2, A. S. Klein2, I. K. Kim2

  • Risk Factors for Initial Sub- and Supra-Therapeutic Tacrolimus Trough Levels in Renal Transplant Recipients

    M. Kapugi, K. Cunningham, C. D'Agostino, C. Kane, A. Novak, J. Schulte

  • Risk Factors for Post-Transplant Outcomes in Living and Deceased Donor Liver Transplantation. An Analysis of UNOS Registry

    T. Kitajima, S. Nagai, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud

  • Risk Factors for Recurrence and Predictors of Response in Kidney Transplant Recipients with Primary FSGS

    A. Uffing1, T. TANGO-consortium2, P. Cravedi3, L. V. Riella1

  • Risk Factors for Recurrent Urinary Tract Infections and Antimicrobial Resistant Organisms in Kidney Transplant Recipients

    S. Greissman1, A. Mattiazzi2, J. Quinonez1, M. Grady1, R. Zukerman1, A. Wawrzyniak3, M. Morris4, S. Anjan4, J. Simkins4, J. Camargo4, L. Abbo5

  • Risk Factors for Sensitization in the Failing Allograft: A Multi-Center Experience

    M. Lubetzky1, O. Mohammed2, N. Hauser1, R. Friedlander1, V. Sharma1, A. Colovai2, T. Muthukumar1, J. Lee1, E. Akalin2, D. Dadhania1

  • Risk Factors to Define an Extended Criteria Donor Heart Do Not Appear to Have Cumulative Adverse Effects after Heart Transplantation

    M. Olymbios, S. Dimbil, R. J. Levine, F. Esmailian, J. Patel, J. A. Kobashigawa

  • Risk of Delayed Graft Function after Deceased Donor Kidney Transplantation in the Current Era

    I. Helanterä1, H. N. Ibrahim2, M. Lempinen1, P. Finne3

  • Risk of Opportunistic Infection in Kidney Transplant Recipients with Cytomegalovirus Infection and Associated Outcomes

    M. Jorgenson1, J. Descourouez1, B. Cardinale2, B. Lyu3, B. Astor3, N. Garg3, C. Saddler3, J. Smith3, D. Mandelbrot3

  • Risk Predictive Strategy to Expand Pancreas Donor Selection

    J. W. Mensink1, K. M. Ooms - de Vries2, V. A. Huurman1, R. A. Pol3, I. P. Alwayn1, A. E. Braat1

  • Risk Stratification of Cytomegalovirus Seropositive Kidney Transplant Recipients for CMV Infection

    M. M. Azar1, A. Baghban1, K. Belfield1, R. Assi2, M. Malinis1

  • Risk Stratification of Patients Undergoing Simultaneous Liver Transplantation and Cardiac Surgery

    T. Diago Uso, G. D'Amico, S. Armanyous, L. Lomaglio, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, N. K. Menon, M. Fares, M. Tong, K. Hashimoto, C. Miller, C. Quintini

  • Rituximab Desensitization to Liver Transplantaiton Recipients with Preformed Donor Specific Antibodies to Prevent Antibody Mediated Rejecton

    Y. Ogura, M. Shizuku, N. Kurata, K. Jobara, H. Kamei

  • Rituximab Protects against Development of Atherosclerotic Cardiovascular Disease after Kidney Transplantation, a Propensity Matched Analysis

    D. Kim, J. Lee, J. Lee, B. Kim, M. Kim, S. Soon Il, Y. Kim, K. Huh, S. Kim, D. Joo, K. In, E. Kim

  • RNA Sequencing Guided Identification of Shared mRNAs in Human Kidney Allograft Recipients with Acute T Cell Mediated Rejection or Active Antibody Mediated Rejection

    B. Dooley1, A. Verma2, R. Ding1, C. Li1, C. Snopkowski1, H. Yang1, B. Botticelli1, S. Albakry1, E. Edusei1, T. Muthukumar1, M. Lubetzky1, D. Dadhania1, J. Lee1, O. Elemento2, M. Suthanthiran1

  • RNA Sequencing Identifies a Differential Role of Coding and Non-Coding Genes by Types of Rejection

    S. Pineda1, O. Bestard2, T. K. Sigdel1, M. Sirota3, M. Sarwal1

  • RNA Splicing and Lineage Progression: Identification of an Integrated Splicing Pattern in Endodermal Lineage Progression

    J. Fair1, N. Liu1, S. G. Widen2, W. S. Fagg1

  • Robotic Assisted Kidney Transplant Outcomes in Obese Candidates

    I. G. Tzvetanov, K. A. Tulla, O. T. Okoye, C. Di Bella, P. Di Cocco, J. A. Almario Alvarez, M. Spaggiari, E. Benedetti

  • Robotic Donor Nephrectomy: Is It Safe Alternative?

    D. Friedman, R. Shahbazov, I. Bandler, T. Malik, Z. Acun, K. Olivera-Wright, B. Gallay, O. Pankewycz, M. Laftavi

  • Robotic Kidney Transplantation For Obese Patients: First Year Experience In Single Institute

    S. Lee1, L. A. Cantrell2, A. Agarwal1, S. K. Rasmussen1, S. Pelletier1, K. Brayman1, J. Oberholzer1

  • Robotic Pancreas Kidney Transplantation For Type 1 Diabetic Patient With End stage Renal Disease: First Year Experience In Single Institute

    S. Lee1, L. A. Cantrell2, A. Agarwal1, S. K. Rasmussen1, S. Pelletier1, K. Brayman1, J. Oberholzer1

  • Robotic-Assisted versus Open Techniques for Living Donor Kidney Transplant Recipients: A Comparison Using Propensity Score Analysis

    F. Tinney, J. Stracke, S. Nagai, L. Malinzak, T. McEvoy, S. Mohamed Ilias, A. Yoshida

  • Robotic-Assisted versus Open- Kidney Transplantation in Non-Obese Recipients

    P. R. Modi, B. Pal, S. Singla, R. Chauhan, V. Kothari, A. Mishra, M. Modi, B. Butala, V. Kute, H. Patel, V. Trivedi

  • Role of Innate Allorecognition Pathways in Mouse Renal Allograft Rejection

    D. Zhao1, H. Dai1, K. Abou-Daya1, A. Williams1, M. Oberbarnscheidt1, X. Li2, F. Lakkis1

  • Role of Kidney Biopsy in Simultaneous Heart-Kidney Transplantation

    P. B. Shah1, M. A. Josephson1, K. Henriksen2, A. Chang2

  • Role of MHC Class II in B Cell and Regulatory T Cell Development

    S. K. Germana, Z. Wang, C. A. Huang, L. Kojima, C. G. Rickert, J. F. Markmann, C. LeGuern

  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation

    S. Bontha1, A. Bajwa1, G. Lorenzo2, J. Eason3, D. Maluf4, V. Mas5

  • Role of Molecular Microscope in the Interpretation of Endarteritis and Acute Thrombotic Microangiopathy

    M. Ciszek1, A. Perkowska-Ptasińska1, D. Deborska-Materkowska1, A. Debska-Slizien2, P. F. Halloran3, M. Myslak4

  • Role of NF-kB in Release of Isletokines via Exosomes in Response to Islet Stress

    P. Saravanan1, M. Kanak1, J. Kalivarathan1, M. Lawrence2, M. Levy1, B. Naziruddin3

  • Role of Procurement and Reperfusion Biopsy in Kidney Transplant in Evaluating and Predicting Outcomes of Deceased Donor Kidneys

    S. Faiz, A. Pai, A. De Golovine, A. Edwards, W. Glass, A. Tchakarov

  • Role of RIPK3 in Chronic Rejection Following Human Lung Transplantation

    S. Angara, R. Ravichandran, H. Sodawalla, M. Smith, R. Bremner, T. Mohanakumar

  • Room for Improvement: Adherence to Vaccination Recommendations in a Heart Transplant Cohort

    D. Jandhyala, J. D. Lewis

  • Room for Optimism; Improvement in Long-Term Patient and Graft Survival of Kidney Transplants in the United States over the past Three Decades

    C. Wu, A. Rana, N. Galvan, C. O'Mahony, J. Goss, B. Murthy

  • Routine Molecular Clostridioides difficile Screening and Overtreatment in Solid Organ Transplant Recipients

    M. E. Newman1, C. Oehler1, M. Enriquez1, E. Landon1, C. T. Nguyen2, N. N. Pettit2, J. P. Ridgway1, J. Pisano1

Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences